Navigation Links
A Sewage Treatment Plant Goes Underground Using In-Pipe Technology Company, Inc. Bioaugmentation
Date:12/5/2012

ing the season, the local cooperatives are at peak production and the wastewater from the wineries and mills increases the water pollution levels fivefold, so that the planned infrastructure for a town of about 1,800 inhabitants must handle the extra wastewater during August and September making it equivalent to a town of 10,000 inhabitants. "This sudden impact in the process breaks the treatment efficiency of the treatment plant," said Castillo.

In Villalba, the remedy for this season’s increase in organic waste load begins in sewer manholes, under which hangs a plastic box. Each box, or G2 dosing panel, contains a one liter bottle of beneficial, non-pathogenic, naturally occurring bacteria with a small pump that continuously injects the bacteria into the sewage flow. The bacteria begin the digestion process of the sewage long before it reaches the WWTP. These bacteria are the perfect employee: they are harmless to humans, work efficiently at digesting the waste, and require no energy input.

To be effective, treatment is done throughout the year – it is not enough to apply the bacteria only during the season when the wine and olive industries begin to discharge their wastewater. Each month, the service provider replenishes the microbes in the one liter bottles, checks the batteries and condition of each self contained G2 dosing panel. The bacteria establish a beneficial biofilm in the sewer collection system, and in the biofilm community they support each other to provide high rates of metabolism.

The bacteria used are naturally found in rivers and soil where they digest waste. The In-Pipe technology accelerates the process by continuously adding the bacteria at multiple locations in the sewer system in high concentrations. In addition to the improved effluent water quality, the cost of operating the WWTP plant is reduced by 10% explained Antonio Palma, a plant technician working for the Consortium from the Council of Badajoz. Amo
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
2. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
3. Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain
4. Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient Response
5. Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union
6. Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A
7. SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma
8. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
9. LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
10. Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7)
11. Biotech Firm Spun Off from Childrens Hospital Raises $7 Million to Advance Magnetic-Based Vascular Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)...  UCB, a multinational biopharmaceutical company, and Genpact ... designing, transforming, and running intelligent business operations, have ... their close collaboration in driving transformation that achieved ... (GBS) finance organization. The Aecus Innovation ... together effectively to embrace the innovative promise of ...
(Date:6/30/2015)... - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that ... approved the resolutions relating to: (i) a private ... at a price of $2.67 per unit (the ... one common share and 0.075358 common share purchase ... and (ii) the amendment to Resverlogix,s articles to ...
(Date:6/30/2015)... June 30, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: ... developing therapeutics that address unmet medical needs in ... Elston will present at the Cantor Fitzgerald ... 8, 2015Time: , 4:45 PM EDTLocation: , Le ... archive): , www.juniperpharma.com, under  ,Investor, or  ...
(Date:6/30/2015)... WA (PRWEB) , ... June 30, 2015 , ... ... a hydrophilic filter that does not sacrifice selectivity to achieve faster flow rates ... combines extremely fine pores with significant open space to allow easy liquid flow ...
Breaking Biology Technology:UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2New Nanofiber Membrane Provides Fast, Efficient Filtration 2
... St. Jude Medical will add up to 1,200 new, jobs within 36 ... ... Rico, ARECIBO, Puerto Rico, Sept. 19 St. Jude,Medical, Inc. (NYSE: ... Medical recently purchased a facility in Arecibo,s,Santana Industrial Park, which will allow the ...
... PARSIPPANY, N.J., Sept. 19 NPS,Pharmaceuticals, Inc. (Nasdaq: ... Food and,Drug Administration,s Office of Orphan Products Development ... [rDNA origin] for,injection) for the treatment of hypoparathyroidism, ... is no FDA-approved therapy. Hypoparathyroidism afflicts approximately ...
... Sept. 19 NeurogesX, Inc.,(Nasdaq: NGSX ), a ... today that it is scheduled to present,at the 2007 ... Anthony DiTonno, President and Chief Executive Officer, and Jeffery,Tobias, ... Tuesday, September 25, 2007 Time: ...
Cached Biology Technology:St. Jude Medical to Expand Puerto Rico Operations 2PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism 2PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism 3NeurogesX to Present at UBS 2007 Global Life Sciences Conference 2NeurogesX to Present at UBS 2007 Global Life Sciences Conference 3
(Date:6/29/2015)... DUBLIN , June 24, 2015 ... the addition of the "Latin America Biomedical Sensors ... to their offering. The Latin America Biomedical ... at a CAGR of 2.04% over the period 2014-2020 ... that are adaptable to the genetic formulation of each ...
(Date:6/25/2015)... LAKE CITY , June 25, 2015  Imagine ... first steps toward a healthier, happier life. That,s exactly ... is designed to do. The cutting-edge, portable health program ... offers real-life solutions to help improve your lifestyle and ... Association awards dinner and gala Wednesday night, USANA,s THA ...
(Date:6/24/2015)... , June 24, 2015 This report provides ... the next six years. It contains an analysis of ... along with their impact from the short, medium, and ... discusses the industry, market, and technology trends that currently, ... need of concerned authorities to efficiently manage the increasing ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2
... Depending on the level of smoking and leisure time ... have no effect, on the risk of pneumonia, according to ... laboratory studies, vitamin E has influenced the immune system. In ... infections. However, the importance of vitamin E on human infections ...
... researchers at Cardiff University is opening up new possibilities for ... materials such as metal ions into cells, a process which ... One technique currently used is called the ,Trojan Horse, in ... naturally taken up by cells. The Cardiff team, ...
... In the U.S., even zoo gorillas need to switch to ... we believe like humans," said Elena Hoellein Less, a PhD candidate ... heart disease is the number one killer of male Western lowland ... After Brooks, a 21-year-old gorilla, died of heart failure ...
Cached Biology News:Sleeping Trojan horse to aid imaging of diseased cells 2Apes shed pounds while doubling calories, CWRU researcher finds 2Apes shed pounds while doubling calories, CWRU researcher finds 3
... an imaging based plate reader for ... throughput screening which can utilize both ... light sources and cameras in the ... in photon detection technology. It ...
... Experion StdSens reagents and supplies, for ... supplies sufficient to perform standard-sensitivity RNA ... on the Experion automated electrophoresis system. ... 20 microliters RNA StdSens stain, 20 ...
... 3-(3,5-Dibromo-4-hydroxy-benzoyl)-2-ethyl-benzofuran-6-sulfonicacid-(4-(thiazol-2-ylsulfamyl)-phenyl)-amide White solid. PROTECT FROM ... cell-permeable sulfanamido-benzbromarone compound that acts as ... inhibitor of PTP1B (IC 50 ... for PTP1B 403 and PTP1B ...
Anti-NCAPD3 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunoprecipitation, Western Blot...
Biology Products: